Princeton Alpha Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,199
Closed -$244K 578
2016
Q4
$244K Sell
3,199
-9
-0.3% -$684 0.05% 538
2016
Q3
$267K Sell
3,208
-3,552
-53% -$298K 0.05% 541
2016
Q2
$557K Buy
+6,760
New +$557K 0.1% 319
2016
Q1
Sell
-4,970
Closed -$400K 759
2015
Q4
$400K Buy
+4,970
New +$358K 0.07% 406
2015
Q2
Sell
-3,096
Closed -$245K 731
2015
Q1
$245K Sell
3,096
-2,124
-41% -$157K 0.05% 538
2014
Q4
$332K Sell
5,220
-497
-9% -$31.2K 0.09% 386
2014
Q3
$342K Sell
5,717
-2,516
-31% -$144K 0.08% 372
2014
Q2
$441K Buy
+8,233
New +$452K 0.09% 315

Other funds holding CRL

Princeton Alpha Management's CRL Position: Q1 2017 in Review

Princeton Alpha Management sold out of Charles River Laboratories (CRL) in Q1 2017, closing a stake of 3,199 shares — an estimated $244K sold.

Princeton Alpha Management first reported a position in CRL in Q2 2014 and held it in 8 quarters. The position peaked at $557K in Q2 2016. 300 funds tracked by Wall St. Rank hold CRL as of Q1 2017.

  • Princeton Alpha Management reported no remaining Charles River Laboratories position as of Q1 2017 after selling out during the quarter.
  • Princeton Alpha Management sold 3,199 Charles River Laboratories shares in Q1 2017, an estimated $244K.
  • Princeton Alpha Management first reported a position in Charles River Laboratories in Q2 2014 and held it in 8 quarters.
  • Princeton Alpha Management's Charles River Laboratories position peaked at $557K in Q2 2016.
  • 300 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2017.

Based on Princeton Alpha Management's 13F filing for Q1 2017, filed 3 May 2017.